XLV

Crude oil near $98 has pushed 10‑year Treasury yields above 4.8%, the highest since 2023, weighing on the Dow as traders anticipate a Fed rate hike next week.

JPMorgan expects healthcare ETF flows to reverse, pointing to Eli Lilly and AbbVie as potential beneficiaries of a renewed sector rotation.

Eli Lilly shares fell 2% amid a broader healthcare sell‑off, with analysts noting key support levels and a technical breakdown.

The State Street Energy Select Sector SPDR ETF led gains on September 8, 2026, while the State Street Technology Select Sector SPDR lagged.

Pharmaceuticals are rebounding as U.S. drug pricing clarity emerges, shifting focus to patent expirations and innovation-driven differentiation.

On September 7, 2026, the State Street Technology Select Sector SPDR ETF was a top gainer, while the State Street Industrial Select Sector SPDR was a lagger.

Drugmakers are receiving a boost from strong earnings and M&A activity, positioning them as havens in a rocky market.